Identification of shared key genes and pathways in osteoarthritis and sarcopenia patients based on bioinformatics analysis.
10.11817/j.issn.1672-7347.2025.240669
- Author:
Yuyan SUN
1
,
2
,
3
;
Ziyu LUO
1
,
3
,
4
;
Huixian LING
1
;
Sha WU
1
;
Hongwei SHEN
5
;
Yuanyuan FU
1
;
Thainamanh NGO
1
;
Wen WANG
1
;
Ying KONG
1
,
6
Author Information
1. Department of Rehabilitation, Second Xiangya Hospital, Central South University, Changsha
2. sunyy822@
3. com.
4. lzy1215717282@
5. Medical Research Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
6. kongying1502@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
bioinformatics;
extracellular matrix-receptor interaction;
key genes;
osteoarthritis;
sarcopenia
- MeSH:
Sarcopenia/genetics*;
Osteoarthritis/genetics*;
Computational Biology/methods*;
Humans;
Protein Interaction Maps/genetics*;
Animals;
Mice;
Gene Expression Profiling;
Gene Ontology;
Transcriptome;
Male;
Signal Transduction/genetics*;
Gene Regulatory Networks
- From:
Journal of Central South University(Medical Sciences)
2025;50(3):430-446
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Osteoarthritis (OA) and sarcopenia are significant health concerns in the elderly, substantially impacting their daily activities and quality of life. However, the relationship between them remains poorly understood. This study aims to uncover common biomarkers and pathways associated with both OA and sarcopenia.
METHODS:Gene expression profiles related to OA and sarcopenia were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) between disease and control groups were identified using R software. Common DEGs were extracted via Venn diagram analysis. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to identify biological processes and pathways associated with shared DEGs. Protein-protein interaction (PPI) networks were constructed, and candidate hub genes were ranked using the maximal clique centrality (MCC) algorithm. Further validation of hub gene expression was performed using 2 independent datasets. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of key genes for OA and sarcopenia. Mouse models of OA and sarcopenia were established. Hematoxylin-eosin and Safranin O/Fast Green staining were used to validate the OA model. The sarcopenia model was validated via rotarod testing and quadriceps muscle mass measurement. Real-time reverse transcription PCR (real-time RT-PCR) was employed to assess the mRNA expression levels of candidate key genes in both models. Gene set enrichment analysis (GSEA) was conducted to identify pathways associated with the selected shared key genes in both diseases.
RESULTS:A total of 89 common DEGs were identified in the gene expression profiles of OA and sarcopenia, including 76 upregulated and 13 downregulated genes. These 89 DEGs were significantly enriched in protein digestion and absorption, the PI3K-Akt signaling pathway, and extracellular matrix-receptor interaction. PPI network analysis and MCC algorithm analysis of the 89 common DEGs identified the top 17 candidate hub genes. Based on the differential expression analysis of these 17 candidate hub genes in the validation datasets, AEBP1 and COL8A2 were ultimately selected as the common key genes for both diseases, both of which showed a significant upregulation trend in the disease groups (all P<0.05). The value of area under the curve (AUC) for AEBP1 and COL8A2 in the OA and sarcopenia datasets were all greater than 0.7, indicating that both genes have potential value in predicting OA and sarcopenia. Real-time RT-PCR results showed that the mRNA expression levels of AEBP1 and COL8A2 were significantly upregulated in the disease groups (all P<0.05), consistent with the results observed in the bioinformatics analysis. GSEA revealed that AEBP1 and COL8A2 were closely related to extracellular matrix-receptor interaction, ribosome, and oxidative phosphorylation in OA and sarcopenia.
CONCLUSIONS:AEBP1 and COL8A2 have the potential to serve as common biomarkers for OA and sarcopenia. The extracellular matrix-receptor interaction pathway may represent a potential target for the prevention and treatment of both OA and sarcopenia.
